Skip to content

Kush Parmar, Director at Entrada Therapeutics, sold TRDA on Aug 7, 2026

Data as of Oct 16

▼ SELL$358K52,317 shares at $6.85Kush Parmar DirectorTRDA Entrada Therapeutics, Inc.
Watch TRDA
Traded
Aug 7, 2026
Disclosed
Aug 10, 2026
Filed
3 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kush Parmar, Director at Entrada Therapeutics, sold TRDA on Aug 7, 2026TRADEDDISCLOSED
TRDASimilar stocks (XLV — its sector index fund), rebased to TRDA's price on the disclosure day
TRDA since disclosure
−37.1%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Aug 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$647Kdisclosed Aug 10 · filed the same day
  2. ▼ SELLKush Parmar DirectorTRDA Entrada Therapeutics, Inc.$73.5Kdisclosed Aug 10 · filed 4 days after the trade

See every trade on TRDA →